Olympiad Research LP Acquires New Position in Astrana Health, Inc. (NASDAQ:ASTH)

Olympiad Research LP acquired a new stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) during the 4th quarter, Holdings Channel reports. The fund acquired 9,106 shares of the company’s stock, valued at approximately $287,000.

A number of other large investors also recently bought and sold shares of ASTH. Nisa Investment Advisors LLC acquired a new position in shares of Astrana Health in the 3rd quarter valued at $35,000. KBC Group NV acquired a new position in shares of Astrana Health in the 3rd quarter valued at $70,000. Quarry LP acquired a new position in shares of Astrana Health in the 3rd quarter valued at $77,000. Quest Partners LLC acquired a new position in shares of Astrana Health in the 3rd quarter valued at $133,000. Finally, Paloma Partners Management Co acquired a new position in shares of Astrana Health in the 3rd quarter valued at $220,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have weighed in on ASTH. Macquarie upgraded shares of Astrana Health to a “hold” rating in a report on Monday, December 16th. Stifel Nicolaus decreased their price target on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a report on Thursday. Truist Financial reduced their target price on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a report on Monday, January 13th. Finally, Robert W. Baird lifted their target price on shares of Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. Two analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $63.00.

Astrana Health Stock Performance

NASDAQ:ASTH opened at $35.68 on Friday. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $2.01 billion, a price-to-earnings ratio of 27.45, a PEG ratio of 1.44 and a beta of 1.20. The firm’s fifty day simple moving average is $35.06 and its 200 day simple moving average is $44.97. Astrana Health, Inc. has a twelve month low of $29.08 and a twelve month high of $63.20.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.